Aug 5, 2020 04:13PM Horizon Therapeutics (HZNP) Announces Proposed $700M Public Offering of Ordinary Shares

Aug 5, 2020 04:01PM Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares

Mar 11, 2019 04:30PM Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Mar 6, 2019 10:00PM Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares

Mar 4, 2019 04:10PM Horizon Pharma plc Announces Proposed Public Offering of Ordinary Shares

Sep 12, 2016 07:00AM Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business

Jul 13, 2015 12:50PM Horizon Pharma plc Responds to Depomed's Adoption of a Poison Pill

Jul 7, 2015 07:00AM Horizon Pharma plc Proposes to Acquire Depomed, Inc. for $29.25 per Share in an All-Stock Transaction, Representing a 42 Percent Premium to Depomed's Shareholders

Apr 21, 2015 09:48AM Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

Apr 15, 2015 06:47PM Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares

Apr 13, 2015 04:01PM Horizon Pharma plc Announces Proposed Public Offering of Ordinary Shares

Mar 30, 2015 06:00AM Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash